Stay updated with breaking news from Pharmaceutical Security. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead Sciences Inc GILD faces a severe threat from the rise in drug counterfeiting, a global issue highlighted by the World Health Organization's staggering…
Gilead Sciences Inc (NASDAQ: GILD) faces a severe threat from the rise in drug counterfeiting, a global issue highlighted by the World Health Organization's staggering estimate of up to $431 billion in
BrandShield, a leader in global digital risk protection, today announced its Digital Risk Protection Report. In a survey of 200 Chief Information Security Officers (CISOs), BrandShield sought to understand how security leaders are approaching digital risk protection by inquiring about financial losses from online scams, cybersecurity attacks experienced, which external threats are of greatest concern, and more. The report comes as cybercrime losses are estimated to reach $8 trillion in...
New York, NY - BrandShield, a leading global cybersecurity company, today announces its $3.38 million capital raise and strategic exit from the London Stock Exchange (LSE) after close to 3 years of public trading and significant growth while publicly traded. Following a General Meeting held by the company on October 13 that approved the delisting, BrandShield is private again to accelerate its growth stage and increase the value of the company. Since its Reverse Takeover (RTO) on the L...
BrandShield (LSE: BRSD), together with the Pharmaceutical Security Institute, announced its annual Pharma Fraud report following a disruption program carried out from January 2022 to January 2023 involving the monitoring, detecting, and removal of online threats. The new report highlights the extent of global criminal fraud targeting both innocent patients and pharmaceutical companies. The removed listings contained a variety of medicines relating to various cancers, HIV, and type 2 di...